Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.236 SEK | +4.89% | +0.43% | -53.17% |
04-22 | Lipidor AB Postpones the Publication of Annual Report for 2023 | CI |
03-21 | Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2 | CI |
Business Summary
Number of employees: 8
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Drugs for the Treatment of Skin Diseases
100.0
%
| 15 | 100.0 % | 0 | 100.0 % | -99.71% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 15 | 100.0 % | 0 | 100.0 % | -99.71% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 55 | 31/12/17 |
Jan Holmbäck
FOU | Founder | 67 | 31/12/08 |
Charlotta Ekman
DFI | Director of Finance/CFO | 43 | 30/09/22 |
Anders Hagman
PRN | Corporate Officer/Principal | - | 30/09/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gunilla Lundmark
BRD | Director/Board Member | 61 | 31/12/18 |
Denis Angioletti
BRD | Director/Board Member | 56 | 31/12/19 |
Ola Flink
BRD | Director/Board Member | 80 | 31/12/16 |
Director/Board Member | 62 | 31/12/19 | |
Chairman | 44 | 31/12/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,976,863 | 18,910,757 ( 65.26 %) | 0 | 65.26 % |
Company contact information
Lipidor AB
Karolinska Institutet Science Park Fogdevreten 2
171 65, Solna
+46 7 25 07 03 69
http://www.lipidor.seSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.17% | 603K | |
+32.19% | 588B | |
-3.14% | 364B | |
+19.44% | 326B | |
+4.69% | 285B | |
+15.51% | 239B | |
+10.36% | 210B | |
-7.20% | 200B | |
+8.94% | 167B | |
-0.42% | 161B |
- Stock Market
- Equities
- LIPI Stock
- Company Lipidor AB